ArticleScientific reports2026
Predictive modelling of the COMATOSE transporter reveals a conserved ligand binding pocket for acyl-CoAs.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The ABCD subfamily is comprised of mainly peroxisomal ABC transporter proteins which are found in most eukaryotes. They import a range of substrates of the peroxisomal β oxidation pathway. In plants there is a single peroxisomal ABC transporter AtABCD1 also known as COMATOSE (CTS), PXA1, PED3 or ACN1. Substrates are acyl CoAs and CTS possesses intrinsic acyl CoA thioesterase activity (ACOT), which has subsequently been demonstrated in human and yeast homologues. Even though there is no sequence similarity to any known thioesterases, the CoA moiety is cleaved at some point during transport and most likely released within the peroxisome. While there is a wealth of published biochemical and genetic data on CTS, the precise transport mechanism remains unknown. To gain insights into the CTS transport cycle we have utilised AlphaFold2/3 to produce high confidence models allowing us to explore the apo, post-translocation and post hydrolysis states of the protein, and used the available genetic and biochemical data to validate our models. Docking simulations of these models and C22:0-CoA/ CoA revealed key residues, which we propose are part of the putative binding pocket for the acyl CoAs. The D863/Q864/T867 (DQT) triad likely plays a structural role, while the proximity of S810 to the CoA-binding pocket suggests a potential involvement in substrate recognition or binding. Conservation scores and the alignments of CTS models with the cryoEM determined substrate-bound human homologue structures, supported the key interactors of the pocket which can inform future experiments to understand the transport mechanism of this important protein.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.